Cryomass Technologies Stock Shares Owned By Institutions
| CRYM Stock | USD 0.02 0.0003 1.89% |
Cryomass Technologies fundamentals help investors to digest information that contributes to Cryomass Technologies' financial success or failures. It also enables traders to predict the movement of Cryomass OTC Stock. The fundamental analysis module provides a way to measure Cryomass Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cryomass Technologies otc stock.
Cryomass |
Cryomass Technologies OTC Stock Shares Owned By Institutions Analysis
Cryomass Technologies' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 0.0% of Cryomass Technologies are shares owned by institutions. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The shares owned by institutions for all United States stocks is 100.0% higher than that of the company.
Cryomass Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cryomass Technologies' direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cryomass Technologies could also be used in its relative valuation, which is a method of valuing Cryomass Technologies by comparing valuation metrics of similar companies.Cryomass Technologies is currently under evaluation in shares owned by institutions category among its peers.
Cryomass Fundamentals
| Return On Equity | -1.16 | |||
| Return On Asset | -0.33 | |||
| Current Valuation | 42.41 M | |||
| Shares Outstanding | 202.53 M | |||
| Shares Owned By Insiders | 25.92 % | |||
| Price To Book | 4.44 X | |||
| Gross Profit | 37.18 K | |||
| EBITDA | (7.9 M) | |||
| Net Income | (12.86 M) | |||
| Cash And Equivalents | 2.19 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 177.08 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 2.07 X | |||
| Book Value Per Share | 0.05 X | |||
| Cash Flow From Operations | (5.6 M) | |||
| Earnings Per Share | (0.08) X | |||
| Beta | 5.22 | |||
| Market Capitalization | 35.44 M | |||
| Total Asset | 15.58 M | |||
| Net Asset | 15.58 M |
About Cryomass Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cryomass Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cryomass Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cryomass Technologies based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Cryomass OTC Stock
Cryomass Technologies financial ratios help investors to determine whether Cryomass OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cryomass with respect to the benefits of owning Cryomass Technologies security.